
Novonesis Investor Relations Material
Latest events

Q1 2025
Novonesis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novonesis
Access all reports
Novonesis develops, produces and sells industrial enzymes, microorganisms and probiotics. The products convert raw materials into food, beverages and biofuels; they also improve the production of crops and plant products, as well as animal feed. Manufacturing microorganisms, enzymes and probiotics for the industrial, biotech and food markets, Novonesis creates innovative solutions that improve their customers' fermentation processes. Their development centres in Europe, USA and Asia help the company to develop consistent and cost-efficient solutions for their partners worldwide.
Key slides for Novonesis


M&A Announcement
Novonesis


Q1 2025
Novonesis
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NSIS
Country
🇩🇰 Denmark